Jeffrey L. Ives
Known title: DirectorCIK: 0001614096
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Tvardi releases preclinical data on STAT3 inhibitor for UC. Tvardi Therapeutics reported new preclinical results that show its STAT3 inhibitor may be effective in treating ulcerative colitis. The data were published in the International Journal of Molecular Sciences. The announcement appeared in recent market round‑ups of health‑care stocks moving in pre‑market and after‑hours sessions.
Transaction History
| ABOS | ▲ Buy | Grant | 35,500 | $0 | 6/3/2026 | View on chart |
| ABOS | ▲ Buy | Grant | 12,800 | $0 | 6/4/2025 | View on chart |
| TVRD | ▲ Buy | Grant | 150,647 | $0 | 6/4/2024 | View on chart |
| ABOS | ▲ Buy | Option Exercise | 39,149 | $28K | 8/17/2023 | View on chart |
| ABOS | ▼ Sell | Open Market | 39,149 | $254K | 8/17/2023 | View on chart |
| ABOS | ▲ Buy | Option Exercise | 2,800 | $3K | 8/17/2023 | View on chart |
| ABOS | ▼ Sell | Open Market | 2,800 | $19K | 8/17/2023 | View on chart |
| TVRD | ▲ Buy | Grant | 32,362 | $0 | 6/1/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 3,600 | $33K | 7/15/2022 | View on chart |
| TVRD | ▲ Buy | Grant | 11,876 | $0 | 6/2/2022 | View on chart |
| TVRD | ▼ Sell | Open Market | 8,180 | $131K | 11/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Acumen Pharmaceuticals Featured in Alzheimer's Day Stock List
Acumen Pharmaceuticals was included in a Yahoo Finance article highlighting four Alzheimer's drug stocks to watch on World Alzheimer's Day. The mention serves as a reminder of the company's focus on neurodegenerative diseases, though the article does not report any new clinical data or corporate announcements. The stock is currently trading near its 52-week low, with an average analyst target of $7.60.
Acumen Pharmaceuticals Featured in Alzheimer's Day Stock List. Acumen Pharmaceuticals was included in a Yahoo Finance article highlighting four Alzheimer's drug stocks to watch on World Alzheimer's Day. The mention serves as a reminder of the company's focus on neurodegenerative diseases, though the article does not report any new clinical data or corporate announcements. The stock is currently trading near its 52-week low, with an average analyst target of $7.60.